Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 4

1(25.0%)

4Total

N/A(3)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06465043Recruiting

HFPEF-project: Heart Failure Phenotyping - Exploring the Fingerprints

Role: collaborator

NCT01742702Unknown

HaemoDYNAMICs in Primary and Secondary Hypertension

Role: collaborator

NCT04556422Not ApplicableCompleted

Comparison of Acute Sauna With Exercise and Sauna

Role: collaborator

NCT02648464Phase 4Completed

Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial

Role: collaborator

NCT01463813Not ApplicableCompleted

Finnish Vitamin D Trial (FIND)

Role: collaborator

NCT01838746Unknown

CRAGS (Coronary aRtery diseAse in younG adultS)

Role: collaborator

NCT01185912Completed

Cardiomyocyte Apoptosis Following Antegrade and Retrograde Cardioplegia

Role: collaborator

NCT01374867Completed

CardShock Study and Registry

Role: collaborator

NCT01479933Not ApplicableCompleted

Glucose Metabolism Effects of Vitamin D Supplementation in Prediabetes

Role: collaborator

NCT00828698Completed

FINGER; Finland-Germany Myocardial Infarction Study

Role: collaborator

All 10 trials loaded